Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue

International Journal of Cancer

Volumn 118, Issue 5, 2006, Pages 1090-1097

  Meinl, Walter ^a   Pabel, Ulrike ^a   Osterloh Quiroz, Mandy ^a   Hengstler, Jan G ^b   Glatt, Hansruedi ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b Rudolf Boehm Institute of Pharmacology and Toxicology   (Germany)

Author keywords

Aristolochic acids; Mutagenicity; Nephropathy; Renal expression; Sulphotransferase

Indexed keywords

ARISTOLOCHIC ACID; HERBACEOUS AGENT; PENTACHLOROPHENOL; SULFOTRANSFERASE; SULFURIC ACID;

ADULT; AGED; ANIMAL CELL; ARISTOLOCHIA; ARTICLE; CHINESE HAMSTER; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; KIDNEY DISEASE; KIDNEY PARENCHYMA; MALE; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; TARGET ORGAN;

AGED; ANIMALS; ARISTOLOCHIC ACIDS; CELL LINE; CRICETINAE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KIDNEY; LIVER; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; MUTAGENESIS; ORGAN SPECIFICITY; RECOMBINANT PROTEINS; SALMONELLA TYPHIMURIUM; SULFOTRANSFERASES;

EID: 31844448260     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21480     Document Type: Article

References (58)

1. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D. Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R, Vanhaelen M. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993;341:387-91.
2. International Agency for Research on Cancer. Aristolochia species and aristolochic acids. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol.82. Lyon: IARC, 2002.69-128.
3. Schmeiser HH, Bieler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 1996;56:2025-8.
4. Cosyns JP, Dehoux JP, Guiot Y, Goebbels RM, Robert A, Bernard AM, van Ypersele de Strihou C. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int 2001;59: 2164-73.
5. Hadjiolov D, Fernando RC, Schmeiser HH, Wiessler M, Hadjiolov N, Pirajnov G. Effect of diallyl sulfide on aristolochic acid-induced forestomach carcinogenesis in rats. Carcinogenesis 1993;14:407-10.
6. Mengs U. On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch Toxicol 1983;52:209-20.
7. Mengs U. Tumour induction in mice following exposure to aristolochic acid. Arch Toxicol 1988;61:504-5.
8. Debelle FD, Nortier JL, De Prez EG, Garbar CH, Vienne AR, Salmon IJ, Deschodt-Lanckman MM, Vanherweghem JL. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol 2002;13:431-6.
9. Mengs U, Lang W, Poch J-A. The carcinogenic action of aristolochic acid in rats. Arch Toxicol 1982;51:107-I9.
10. Stiborová M, Hajek M, Frei E, Schmeiser HH. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH: cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy. Gen Physiol Biophys 2001;20:375-92.
11. Stiborová M, Frei E, Wiessler M, Schmeiser HH. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chem Res Toxicol 2001;14:1128-37.
12. Stiborová M, Frei E, Sopko B, Wiessler M, Schmeiser HH. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy. Carcinogenesis 2002;23:617-25.
13. Robisch G, Schimmer O, Göggelmann W. Aristolochic acid is a direct mutagen in Salmonella typhimurium. Mutation Res 1982;105: 201-4.
14. Schmeiser HH, Pool BL, Wiessler M. Mutagenicity and in vitro metabolism of aristolochic acid. Biochem Pharmacol 1985;34:455-6.
15. Pezzuto JM, Swanson SM, Mar W, Che CT, Cordell GA, Fong HH. Evaluation of the mutagenic and cytostatic potential of aristolochic acid (3,4-methylenedioxy-8-methoxy-10-nitrophenanthrene-1-carboxylic acid) and several of its derivatives. Mutation Res 1988;206:447-54.
16. Bartsch H. Metabolic activation of aromatic amines and azo dyes. IARC Sci Publ 1981;40:13-30.
17. Rosenkranz HS, Mermelstein R. Mutagenicity and genotoxicity of nitroarenes: all nitro-containing chemicals were not created equal. Mutation Res 1983;114:217-67.
18. Glatt HR. Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 2000;129:141-70.
19. Glatt HR, Meinl W. Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity. Carcinogenesis 2004;25: 779-86.
20. Glatt HR, Pabel U, Meinl W, Frederiksen H, Frandsen H, Muckel E. Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b]indole (MeAαC) in recombinant test systems expressing human xenobiotic-metabolizing enzymes. Carcinogenesis 2004;25:801-7.
21. Meinl W, Meerman JH, Glatt HR. Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium. Pharmacogenetics 2002;12:677-89.
22. Muckel E, Frandsen H, Glatt HR. Heterologous expression of human N-acetyltransferases 1 and 2 and sulfotransferase 1A1 in Salmonella typhimurium for mutagenicity testing of heterocyclic amines. Food Chem Toxicol 2002;40:1063-8.
23. Glatt HR. Sulphotransferases. In: Ioannides C, ed. Handbook of enzyme systems that metabolise drugs and other xenobiotics. Sussex: John Wiley, 2002.353-439.
24. Coughtrie MWH, Sharp S, Maxwell K, Innes NP. Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem Biol Interact 1998;109:3-27.
25. Falany CN. Sulfation and sulfotransferases: 3. enzymology of human cytosolic sulfotransferases. FASEB J 1997;11:206-16.
26. Vanherweghem JL. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herb nephropathy). J Altern Complement Med 1998;4:9-13.
27. 32P-postlabeling analysis of DNA adduct formation. Mutation Res 2001;493:149-60.
28. Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 1997;239:298-304.
29. Glatt HR, Meinl W. Pharmacogenetics of soluble sulfotransferases (SULTs). Naunyn Schmiedebergs Arch Pharmacol 2004;369:55-68.
30. Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutation Res 1983;113:173-215.
31. Freimuth RR, Wiepert M, Chute CG, Wieben ED, Weinshilboum RM. Human cytosolic sulfotransferase database mining: identification of seven novel genes and pseudogenes. Pharmacogenomics J 2004;4: 54-65.
32. Glatt HR, Gemperlein I, Setiabudi F, Platt K-L, Oesch F. Expression of xenobiotic-metabolising enzymes in propagatable cell cultures and induction of micronuclei by 13 compounds. Mutagenesis 1990;5:241-9.
33. Czich A, Bartsch I, Dogra S, Hornhardt S, Glatt HR. Stable heterologous expression of hydroxysteroid sulphotransferase in Chinese hamster V79 cells and their use for toxicological investigations. Chem Biol Interact 1994;92:119-28.
34. Kreis P, Brandner S, Coughtrie MWH, Pabel U, Meinl W, Glatt HR, Andrae U. Human phenol sulfotransferases hP-PST and hM-PST activate propane 2-nitronate to a genotoxicant. Carcinogenesis 2000;21: 295-9.
35. Liu Y-G, Muckel E, Doehmer J, Glatt HR. Phenol and hydroquinone induce gene mutations in V79-derived cells expressing human xenobiotic-metabolising enzymes. Nova Acta Leopoldina NF87 2003;329: 231-7.
36. Schmalix WA, Barrenscheen M, Landsiedel R, Janzowski C, Eisenbrand G, Gonzalez F, Eliasson E, Ingelman-Sundberg M, Perchermeier M, Greim H, Doehmer J. Stable expression of human cytochrome P450 2E1 in V79 Chinese hamster cells. Eur J Pharmacol 1995;293: 123-31.
37. Meerman JH, van Doom AB, Mulder GJ. Inhibition of sulfate conjugation of N-hydroxy-2-acetylaminofluorene in isolated perfused rat liver and in the rat in vivo by pentachlorophenol and low sulfate. Cancer Res 1980;40:3772-9.
38. Glatt HR, Davis W, Meinl W, Hermersdörfer H, Venitt S, Phillips DH. Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture. Carcinogenesis 1998;19:1709-13.
39. Teubner W, Meinl W, Glatt HR. Stable expression of rat sulfotransferase 1B1 in V79 cells: activation of benzylic alcohols to mutagens. Carcinogenesis 2002;23:1877-84.
40. Rubin GL, Sharp S, Jones AL, Glatt HR, Mills JA, Coughtrie MWH. Design, production and characterization of antibodies discriminating between the phenol- and monoamine-sulphating forms of human phenol sulphotransferase. Xenobiotica 1996;26:1113-9.
41. Falany CN, Krasnykh V, Falany JL. Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase. J Steroid Biochem Mol Biol 1995;52:529-39.
42. Schmeiser HH, Pool BL, Wiessler M. Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in Salmonella typhimurium. Cancer Lett 1984;23:97-101.
43. Götzl E, Schimmer O. Mutagenicity of aristolochic acids (I, II) and aristolic acid I in new YG strains in Salmonella typhimurium highly sensitive to certain mutagenic nitroarenes. Mutagenesis 1993;8:17-22.
44. Wang J, Falany JL, Falany CN. Expression and characterization of a novel thyroid, hormone-sulfating form of cytosolic sulfotransferase from human liver. Mol Pharmacol 1998;53:274-82.
45. Glatt HR, Teubner W, Meinl W. Sulfotransferases expressed in the human gastro-intestinal tract and their ability to activate promutagens/carcinogens. In: Oesch F, ed. 15th international symposium on microsomes and drug oxidations. Bologna: Medimond/Monduzzi, 2005.9-15.
46. Vietri M, Pietrabissa A, Mosca F, Spisni R, Pacifici GM. Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues. Xenobiotica 2003;33:357-63.
47. Hume R, Coughtrie MWH. Phenolsulphotransferase: localization in kidney during human embryonic and fetal development. Histochem J 1994;26:850-5.
48. Zhu XY, Veronese ME, Iocco P, McManus ME. cDNA cloning and expression of a new form of human aryl sulfotransferase. Int J Biochem Cell Biol 1996;28:565-71.
49. Ozawa S, Tang YM, Yamazoe Y, Kato R, Lang NP, Kadlubar FF. Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem Biol Interact 1998;109: 237-48.
50. Dooley TP, Haldeman-Cahill R, Joiner J, Wilborn TW. Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem Biophys Res Commun 2000;277:236-45.
51. Glatt HR, Meinl W, Kuhlow A, Ma L. Metabolic formation, distribution and toxicological effects of reactive sulphuric acid esters. Nova Acta Leopoldina NF87 2003;329:151-61.
52. Ma L, Kuhlow A, Glatt HR. Albumin strongly prolongs the lifetime of chemically reactive sulphuric acid esters and affects their biological activities in the rat. Nova Acta Leopoldina NF87 2003;329: 265-72.
53. Pacifici GM, Giulianetti B, Quilici MC, Spisni R, Nervi M, Giuliani L, Gomeni R. (-)-salbutamol sulphation in the human liver and duodenal mucosa: interindividual variability. Xenobiotica 1997;27:279-86.
54. Bamforth KJ, Dalgliesh K, Coughtrie MWH. Inhibition of human liver steroid sulfotransferase activities by drugs: a novel mechanism of drug toxicity. Eur J Pharmacol 1992;228:15-21.
55. Harris RM, Hawker RJ, Langman MJS, Singh S, Waring RH. Inhibition of phenolsulphotransferase by salicylic acid: a possible mechanism by which aspirin may reduce carcinogenesis. Gut 1998; 42:272-5.
56. Vietri M, De Santi C, Pietrabissa A, Mosca F, Pacifici GM. Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs. Eur J Clin Pharmacol 2000;56:81-7.
57. Ghazali RA, Waring RH. The effects of flavonoids on human phenolsulphotransferases: potential in drug metabolism and chemoprevention. Life Sci 1999;65:1625-32.
58. Coughtrie MWH, Johnston LE. Interactions between dietary chemicals and human sulfotransferases: molecular mechanisms and clinical significance. Drug Metab Dispos 2001;29:522-8.